ArticleCommunications medicine2025
Enhanced large language models for effective screening of depression and anxiety.
Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Feasibility and user evaluation of HopeBot: An LLM-powered conversational chatbot for depression screening.PLOS digital health · 2026Article
- Large Language Models for Depression Detection: A Review with Prospects of Incomplete Multimodality.Brain sciences · 2026Review
- Large Language Model Adaptation Strategies in Speech-Based Cognitive Screening: Systematic Evaluation.JMIR AI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepressive and anxiety disorders are widespread, necessitating timely identification and management. These conditions manifest through various emotional and behavioral symptoms, such as persistent sadness and excessive worry. When left undiagnosed and untreated, these disorders can cause severe consequences, including increased risk of suicide and substantial socioeconomic burden. Recent advances in Large Language Models (LLMs) offer potential solutions, yet high costs and ethical concerns about training data remain challenges.
methodsThis paper introduces a pipeline for synthesizing clinical interviews, resulting in 1,157 interactive dialogues (PsyInterview), and presents EmoScan, an LLM-based emotional disorder screening system. EmoScan distinguishes between coarse (e.g., anxiety or depressive disorders) and fine disorders (e.g., major depressive disorders) and conducts high-quality interviews.
resultsEvaluations show that EmoScan exceeds the performance of base models and other LLMs like GPT-4 in screening emotional disorders (F1-score = 0.7467). It also delivers superior explanations (BERTScore=0.9408) and demonstrates robust generalizability (F1-score of 0.67 on an external dataset). Furthermore, EmoScan outperforms baselines in interviewing skills, as validated by automated ratings and human evaluations.
conclusionsThis work highlights the importance of scalable data-generative pipelines for developing effective mental health LLM tools.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.